FI903365A0 - 6- och 7-deoxiforskoliner, derivat av dessa, intermediat och foerfarande foer framstaellning av dessa och anvaendning av dem som laekemdel. - Google Patents

6- och 7-deoxiforskoliner, derivat av dessa, intermediat och foerfarande foer framstaellning av dessa och anvaendning av dem som laekemdel.

Info

Publication number
FI903365A0
FI903365A0 FI903365A FI903365A FI903365A0 FI 903365 A0 FI903365 A0 FI 903365A0 FI 903365 A FI903365 A FI 903365A FI 903365 A FI903365 A FI 903365A FI 903365 A0 FI903365 A0 FI 903365A0
Authority
FI
Finland
Prior art keywords
och
dessa
laekemdel
deoxiforkoliner
intermediat
Prior art date
Application number
FI903365A
Other languages
English (en)
Inventor
Jr Raymond Walter Kosley
Bettina Spahl
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI903365A0 publication Critical patent/FI903365A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
FI903365A 1989-07-06 1990-07-04 6- och 7-deoxiforskoliner, derivat av dessa, intermediat och foerfarande foer framstaellning av dessa och anvaendning av dem som laekemdel. FI903365A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/376,383 US5093336A (en) 1989-07-06 1989-07-06 6- and 7-deoxyforskolin and derivatives thereof

Publications (1)

Publication Number Publication Date
FI903365A0 true FI903365A0 (fi) 1990-07-04

Family

ID=23484803

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903365A FI903365A0 (fi) 1989-07-06 1990-07-04 6- och 7-deoxiforskoliner, derivat av dessa, intermediat och foerfarande foer framstaellning av dessa och anvaendning av dem som laekemdel.

Country Status (13)

Country Link
US (1) US5093336A (fi)
EP (1) EP0406789A1 (fi)
JP (1) JPH0344385A (fi)
KR (1) KR910002830A (fi)
AU (1) AU5870190A (fi)
CA (1) CA2020542A1 (fi)
FI (1) FI903365A0 (fi)
HU (1) HUT55771A (fi)
IE (1) IE902437A1 (fi)
IL (1) IL94974A0 (fi)
NO (1) NO903007L (fi)
PT (1) PT94602A (fi)
ZA (1) ZA905263B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646175A (en) * 1987-12-28 1997-07-08 Hoechst Marion Roussel, Inc. Carbamoyloxylabdane compounds
US4920146A (en) * 1986-12-29 1990-04-24 Hoechst Roussel Pharmaceuticals Inc. Carbamoyloxylabdane compounds useful in reducing intraocular pressure
US6737084B2 (en) 2000-06-27 2004-05-18 Qualilife Compositions and methods for enhancing or treating female sexual response

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557784C2 (de) * 1975-12-22 1986-04-17 Hoechst Ag, 6230 Frankfurt Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate
DE2640275A1 (de) * 1976-09-08 1978-03-09 Hoechst Ag Pharmakologisch wirksame substanz aus labiaten
DE2654796A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Polyoxygenierte labdan-derivate
US4517200A (en) * 1982-12-27 1985-05-14 Schering-Plough Corporation Method for treating allergic reactions with forskolin
US4564626A (en) * 1983-04-01 1986-01-14 Schering Corporation Methods of inducing bronchodilation
DE3314999A1 (de) * 1983-04-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verwendung des diterpen-derivates forskolin zur immunstimulation
US4476140A (en) * 1983-05-16 1984-10-09 Yale University Composition and method for treatment of glaucoma
DE3407514A1 (de) * 1984-03-01 1985-09-26 Hoechst Ag, 6230 Frankfurt Verwendung von polyoxygenierten labdanderivaten zur behandlung von konstriktionen der atemwege
DE3502685A1 (de) * 1985-01-26 1986-09-04 Hoechst Ag, 6230 Frankfurt Forskolin, seine analoge und derivate, verfahren zu deren herstellung mittels mikrobieller umwandlungen und die anwendung dieser verbindungen als arzneimittel
DE3502686A1 (de) * 1985-01-26 1986-08-14 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von labdan-derivaten und ihre verwendung als arzneimittel
US4672115A (en) * 1984-12-14 1987-06-09 Hoechst-Roussel Pharmaceuticals Inc. Process for preparing aminoacyllabdanes
US4666904A (en) * 1984-12-14 1987-05-19 Hoechst-Roussel Pharmaceuticals Inc. Aminoacyllabdanes, pharmacuetical compositions and use
US4673752A (en) * 1984-12-14 1987-06-16 Hoechst-Roussel Pharmaceuticals Inc. Aminoacyllabdanes
US4639446A (en) * 1984-12-14 1987-01-27 Hoechst-Roussel Pharmaceuticals Inc. Aminoacyllabdanes, pharmaceutical compositions and use
EP0193132B1 (en) * 1985-03-01 1991-04-17 Hoechst-Roussel Pharmaceuticals Incorporated Labdan-derivatives, a process for their preparation and their use as medicaments
US4677103A (en) * 1985-03-01 1987-06-30 Hoechst-Roussel Pharmaceuticals Inc. Labdane compounds, pharmaceutical compositions and use
US4639443A (en) * 1985-03-01 1987-01-27 Hoechst-Roussel Pharmaceuticals Inc. Labdane compounds, pharmaceutical compositions and use
US4871764A (en) * 1986-11-20 1989-10-03 Hoechst-Roussel Pharmaceuticals, Inc. 12-Halogenated forskolin derivatives
FI875699A (fi) * 1986-12-29 1988-06-30 Hoechst Roussel Pharma Nya karbamoyloxilabdaner, mellanprodukter och foerfaranden foer deras framstaellning samt deras anvaendning saosom laekemedel.
IN166900B (fi) * 1987-06-03 1990-08-04 Hoechst India

Also Published As

Publication number Publication date
AU5870190A (en) 1991-02-07
IE902437A1 (en) 1991-06-19
HUT55771A (en) 1991-06-28
HU904113D0 (en) 1990-12-28
EP0406789A1 (en) 1991-01-09
US5093336A (en) 1992-03-03
CA2020542A1 (en) 1991-01-07
ZA905263B (en) 1991-03-27
NO903007L (no) 1991-01-07
KR910002830A (ko) 1991-02-26
NO903007D0 (no) 1990-07-05
IL94974A0 (en) 1991-06-10
JPH0344385A (ja) 1991-02-26
PT94602A (pt) 1991-03-20

Similar Documents

Publication Publication Date Title
FI905314A0 (fi) Som positiv fungerande fotoresist och foerfarande foer framstaellning av densamma.
FI872106A (fi) Extrakt av nerium-arter, foerfarande foer framstaellning av dem och deras anvaendning.
FI885052A0 (fi) Katalysatorsystem, som foerhindrar bildning av svavelvaete och som innehaoller kopparoxid.
FI906139A (fi) Halogenerade olefiner, foerfarande foer framstaellning av dessa och anvaendning av dessa som skadedjursbekaempningsmedel.
FI902248A0 (fi) N-heteroaryl-4-kinolinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI900848A0 (fi) Foerfarande foer framstaellning av saodana halvaromatiska polyamider, som innehaoller resten av en eller flera aromatiska dikarboxylsyror och alkylpentametylendiamin.
FI900870A0 (fi) Foerfarande foer belaeggning av papper med kompositioner, som innehaoller mikrokapslar.
FI891222A0 (fi) Arylpiperazinylalkoxiderivat av cykliska imider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI913723A0 (fi) Dihydroxipropylsulfoetylcellulosor, framstaellning och anvaendning av dem.
FI903214A0 (fi) Naftyl- och naftyloxi- pyrimidiner och dessa beroerande foereningar, foerfarande foer deras framstaellning och deras anvaendning som dermatologiska laekemedel.
FI852851A0 (fi) Naftylanaloger av mevalonlakton och derivat av dem, foerfaranden foer framstaellning av dem och deras anvaendning.
FI905689A (fi) 3-aminopyrroler, foerfaranden foer deras framstaellning, och deras anvaendning som laekemedel.
FI870585A (fi) Purinderivat, deras framstaellning och medikament som innehaoller dem.
FI905702A (fi) Kumarinderivat, foerfarande foer framstaellning av dessa, anvaendning av dessa och tiazolylaettikssyraderivat som mellanprodukter.
FI904660A0 (fi) Som fungicider anvaendbara substituerade triazoler, deras framstaellning och kompositioner.
FI901200A0 (fi) Nya steroidderivat, dessa innehaollande farmaceutiska foereningar och foerfarande foer framstaellning av dem.
FI903365A0 (fi) 6- och 7-deoxiforskoliner, derivat av dessa, intermediat och foerfarande foer framstaellning av dessa och anvaendning av dem som laekemdel.
FI902852A0 (fi) Renininhibitoriska peptider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI902199A0 (fi) 5-substituerade 3-aryl-isoxazolderivat, deras framstaellning och deras anvaendning som skadedjursbekaempningsmedel.
FI903237A0 (fi) Fenoxipyridinaminer och deras derivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI894758A (fi) Derivat av 3-aryloximetyl -cefalosporin, deras framstaellning och medicinska anvaendning.
FI920997A0 (fi) Nya amidingrupphaltiga difosforsyrederivat, foerfarande foer framstaellning av dem och laekemedel innehaollande dessa foereningar.
FI872073A (fi) Derivat av propargyloxybenzener, deras framstaellning och fungicida sammansaettningar i vilka de ingaor.
FI900102A (fi) 7-aryl- ochheteroaryletrar av desacetylforskolin, foerfrande foer deras framstaellning och deras anvaending som laekemedel.
FI905647A0 (fi) Uppteckningsmaterial, som innehaoller vinylkarbinol eller derivat daerav.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED